Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Immunol Methods ; 191(2): 179-86, 1996 May 27.
Artigo em Inglês | MEDLINE | ID: mdl-8666837

RESUMO

A flow cytometric assay (FCA), which detects the p24 antigen in HIV-infected cell lines and in peripheral blood mononuclear cells (PBMC) of AIDS patients, has been described in several studies. However, the results presented here clearly show that this p24-FCA, although useful for the analysis of HIV infection of cells in vitro, does not specifically detect HIV-infected PBMC from patients. Isotype control antibodies also stained PBMC from HIV-infected patients to a greater degree than the PBMC from healthy controls. Furthermore, the CD4-negative lymphocytes, which are generally not infected with HIV, were also found to stain with anti-p24. Finally, no enrichment of HIV-infected cells was found in the FACS-purified CD4+p24+ lymphocytes, compared to the CD4+p24- cell fraction. The p24-FCA, therefore, was not useful for determining the percentage of infected PBMCs from HIV-infected individuals.


Assuntos
Síndrome da Imunodeficiência Adquirida/imunologia , Especificidade de Anticorpos , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/virologia , Anticorpos Anti-HIV/química , Proteína do Núcleo p24 do HIV/imunologia , Síndrome da Imunodeficiência Adquirida/virologia , Anticorpos Monoclonais/química , Especificidade de Anticorpos/efeitos dos fármacos , Sequência de Bases , Ligação Competitiva/efeitos dos fármacos , Ligação Competitiva/imunologia , Linhagem Celular , Proteína do Núcleo p24 do HIV/sangue , Proteína do Núcleo p24 do HIV/farmacologia , Humanos , Dados de Sequência Molecular , Coloração e Rotulagem
2.
Phys Rev B Condens Matter ; 51(24): 17535-17541, 1995 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-9978778
3.
Cathet Cardiovasc Diagn ; 24(3): 226-30, 1991 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1764748

RESUMO

In 9 out of 12 patients with a total coronary occlusion but definite signs of viable myocardium a new approach for the recanalization procedure was successfully employed: Following recanalization using an on-the-wire 2.0 or 2.5 mm angioplasty catheter, a standard coronary guidewire was placed along the angioplasty catheter. After withdrawal of the catheter, over-the-wire angioplasty with an appropriately sized balloon was performed for final dilatation. Pending further studies in a larger patient population, this new method may offer an alternative approach for revascularization of total coronary occlusions.


Assuntos
Angioplastia Coronária com Balão/métodos , Idoso , Angina Pectoris/diagnóstico por imagem , Angina Pectoris/terapia , Angioplastia Coronária com Balão/instrumentação , Angiografia Coronária , Feminino , Humanos , Masculino
5.
Am Heart J ; 121(6 Pt 2): 1965-73, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2035428

RESUMO

The systemic and pulmonary arterial hemodynamics of 40 patients with severe congestive heart failure were determined during a 24-hour infusion of milrinone (0.5 micrograms/kg/min) after a loading dose of 50 micrograms/kg. A subgroup (n = 18) with severe cardiac pump dysfunction and three patients in cardiogenic shock were analyzed separately; their hemodynamic response was compared with that of the total group (n = 40). After 15 minutes of intravenous therapy with milrinone, the total group (n = 40) showed an increase of 65% in cardiac index; in the subgroup (n = 18) cardiac index increased by 94% after 15 minutes and by 106% after 30 minutes. Likewise, pulmonary capillary wedge pressure decreased after 30 minutes in both the total group (n = 40) and the subgroup (n = 18). The heart rate showed an overall tendency to decrease. The systolic blood pressure tended upward and remained statistically unchanged in the total group, whereas in the subgroup in which pressure was initially low, there was an increase in the systolic pressure after 1 hour and a further increase after 24 hours. Mean arterial pressure also rose in this subgroup. The early improvement in all measured hemodynamic parameters was sustained throughout the 24-hour infusion period. Development of tolerance was not observed, nor were any clinically symptomatic side effects or symptomatic arrhythmias. Thus intravenous milrinone is a safe medication for the rapid and prolonged improvement in hemodynamics, specifically in patients with severely restricted cardiac pumping function.


Assuntos
Cardiotônicos/administração & dosagem , Insuficiência Cardíaca/tratamento farmacológico , Hemodinâmica/efeitos dos fármacos , Piridonas/administração & dosagem , Choque Cardiogênico/tratamento farmacológico , Adulto , Idoso , Cardiotônicos/farmacologia , Avaliação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Milrinona , Piridonas/farmacologia , Fatores de Tempo
6.
Am Heart J ; 121(6 Pt 2): 1974-83, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1852090

RESUMO

High levels of endogenous plasma catecholamines in patients with severe congestive heart failure induce a down-regulation of the myocardial beta-adrenoreceptors and thus cause adrenoreceptor agonists, such as dobutamine, to be less effective in the treatment of these patients. Phosphodiesterase III inhibitors work independent of adrenoreceptor activity and plasma catecholamine levels; thus these agents are likely to be more effective in the treatment of severe heart failure. The present study compares both the initial and late hemodynamic effects of dobutamine and milrinone during sequentially administered 24-hour infusions. Twenty patients with severe heart failure (New York Heart Association class III, n = 4; New York Heart Association class IV, n = 16) were investigated. Dobutamine could be administered at the prescribed maximum dose of 15 micrograms/kg/min for 24 hours in only 15 of 20 patients. In three patients the dose was reduced or dobutamine infusion completely stopped because of a drug-related increase in heart rate greater than 140 beats/min. Another 2 of 20 patients showed no hemodynamic improvement over 3 hours at the maximum dose of 15 micrograms/kg/min. Dobutamine administration was also discontinued in these patients on account of the existing unfavorable hemodynamic condition, and therapy with intravenous milrinone was started. All 20 patients responded to milrinone without side effects, although comparison of the hemodynamic effects during a 24-hour infusion was possible in only 15 patients. The 15 patients studied over both observation periods experienced an increase in heart rate from 88.8 to 105.6 beats/min (+ 1 hour; p less than or equal to 0.001) when receiving dobutamine but had no increase with milrinone. Stroke volume increased during dobutamine infusion from 19.3 to 28.9 ml/m2 (+49.6%) after 1 hour and then fell continuously to 25.2 ml/m2 after 12 hours; during milrinone therapy, stroke volume increased from 18.8 to 31.2 ml/m2 (+66%; p less than or equal to 0.001) and remained at this level until the end of the infusion (30.2 ml/m2). Pulmonary capillary wedge pressure (PCWP) decreased (p less than or equal to 0.001) immediately during milrinone therapy from 26.5 to 16.2 mm Hg after 30 minutes and stabilized at 20.1 mm Hg after 24 hours. During dobutamine infusion PCWP showed a delayed decrease from 27.8 to 19.0 mm Hg after 6 hours and subsequently rose to 22.7 mm Hg after 24 hours.(ABSTRACT TRUNCATED AT 400 WORDS)


Assuntos
Dobutamina/farmacologia , Insuficiência Cardíaca/tratamento farmacológico , Hemodinâmica/efeitos dos fármacos , Inibidores de Fosfodiesterase/farmacologia , Piridonas/farmacologia , Receptores Adrenérgicos beta/efeitos dos fármacos , Adulto , Idoso , Dobutamina/efeitos adversos , Dobutamina/uso terapêutico , Feminino , Frequência Cardíaca/efeitos dos fármacos , Humanos , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Milrinona , Norepinefrina/sangue , Inibidores de Fosfodiesterase/uso terapêutico , Pressão Propulsora Pulmonar/efeitos dos fármacos , Piridonas/uso terapêutico , Volume Sistólico/efeitos dos fármacos , Fatores de Tempo
7.
Z Kardiol ; 80(4): 272-8, 1991 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-1862668

RESUMO

The hemodynamics of 18 patients (subgroup A) with severe heart failure (baseline Cl less than or equal to 1.55 l.min-1.m-2), including three patients with cardiogenic shock, and another 22 patients (subgroup B) with moderate heart failure (baseline Cl from 1.55 to 2.5 l.min-1.m-2) were investigated during a 24 h milrinone infusion, combined with investigation of the response of the sympathetic tone (plasma catecholamine levels) and the renin-angiotensin-aldosterone system to the hemodynamic improvement in both subgroups. Cl increased (p less than or equal to 0.001) to 162.7% after 5 min and further to 206.4% of baseline after 30 min of milrinone therapy in subgroup A, and in B to 139.3% and further to 146.4% after 15 min. PCWP decreased (p less than or equal to 0.001) to 83.8% and further to 65.5% of baseline after 30 min in subgroup A, and to 58.4% in subgroup B. Heart rate decreased (p less than or equal to 0.05) from 99.4 to 94.7 bpm in A and showed a decreasing tendency in B. MAP rose in A from 75.5 to 79.4 after 1 h and further to 83.3 mm Hg (p less than or equal to 0.01) after 24 h; in subgroup B, MAP did not change. Plasma noradrenaline level decreased (p less than or equal to 0.001) in A from 1419.5 (B: 782.9) to 838.2 (B: 529.6) after 1 h and further to 655.1 (B: 467.9) pg/ml after 24 h. Plasma renin decreased (p less than or equal to 0.01) in A from 1047.6 (B: 460.2) to 597.4 (B: 222.5) and further to 392.6 (B: 191.7) microU/ml.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Cardiotônicos , Insuficiência Cardíaca/tratamento farmacológico , Hemodinâmica/efeitos dos fármacos , Piridonas/administração & dosagem , Sistema Renina-Angiotensina/efeitos dos fármacos , Sistema Nervoso Simpático/efeitos dos fármacos , Adulto , Cardiomiopatia Dilatada/tratamento farmacológico , Cardiomiopatia Dilatada/fisiopatologia , Catecolaminas/sangue , Doença das Coronárias/tratamento farmacológico , Doença das Coronárias/fisiopatologia , Esquema de Medicação , Feminino , Insuficiência Cardíaca/fisiopatologia , Hemodinâmica/fisiologia , Humanos , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Milrinona , Sistema Renina-Angiotensina/fisiologia , Sistema Nervoso Simpático/fisiopatologia
8.
Z Kardiol ; 80(2): 149-57, 1991 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-2058247

RESUMO

Hemodynamics during 24-h dobutamine (dob) and subsequent 24-h milrinone (mil) infusion were studied in 20 patients (pts) with severe heart failure (NYHA III: 4 pts, NYHA IV: 16 pts). Three of 20 patients showed a heart-rate increase to 140 bpm and more during dob; five patients were non-responders to dob. Heart rate rose (p less than or equal to 0.001) during dob from 88.8 to 105.6 bpm (+1 hr) and then decreased to 93.0 bpm after 24 h; stroke volume index increased (p less than or equal to 0.001) from 19.3 to 28.9 ml.m-2 (+49.6%) after 1 h and then decreased to 25.2 ml.m-2 after 12 h as did heart rate. During mil heart rate did not change; stroke volume index increased from 18.8 to 31.2 (+66.0%, p less than or equal to 0.001) after 1 h and showed no development of tolerance during the rest of the infusion period. PCWP decreased (p less than or equal to 0.001) during mil from 26.5 to 16.2 mm Hg after 30 min, tending upward again to 20.1 mm Hg after 24 h; during dob the decrease (p less than or equal to 0.01) of PCWP from 27.8 to 19.0 mm Hg after 6 h was delayed, also tending upward during the rest of the infusion period to 22.7 mm Hg after 24 h. There was no sustained decrease of PVR during dob, but after the start of mil infusion PVR decreased (p less than or equal to 0.001) from 312.7 to 172.1 dynes/s/cm-5 (+15 min), remaining on this level during the rest of mil infusion.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Cardiotônicos , Dobutamina/administração & dosagem , Insuficiência Cardíaca/tratamento farmacológico , Hemodinâmica/efeitos dos fármacos , Piridonas/administração & dosagem , Adulto , Idoso , Cardiomiopatia Dilatada/tratamento farmacológico , Cardiomiopatia Dilatada/fisiopatologia , Doença das Coronárias/tratamento farmacológico , Doença das Coronárias/fisiopatologia , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Insuficiência Cardíaca/fisiopatologia , Hemodinâmica/fisiologia , Humanos , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Milrinona
9.
Med Klin (Munich) ; 85(6): 366-70, 1990 Jun 15.
Artigo em Alemão | MEDLINE | ID: mdl-2377147

RESUMO

Pulmonary embolectomy as an emergent surgical treatment after massive pulmonary embolism often is necessary in cardiogenic shock (CS) and even without previous diagnostic. If complete dissolution of the thromboembolus is possible or spreading of microemboli may occur is unknown. Therefore we studied 21 patients surgically treated by embolectomy, ten of these with consecutive cardiogenic shock (CS) and twelve patients after repetitive microembolism and cava-blocking. Besides lung-functional parameters for special CO-diffusion capacity (DLCO), differentiated in membrane (DM) and vascular (VC) component (Roughton and Forster), we measured mean pulmonary artery pressure (PAP) at rest and at exercise. Patients after repetitive embolism showed considerably more diminution of DLCO (-31%) than those after single massive embolic event (-15%) even concomitant by CS (-10%). Repetitive microembolism lowered VC by 21%. Slight decrease of DM was found after CS. Mean pulmonary artery pressure was elevated at rest (26 mm Hg) and exercise (33 mm Hg) after repetitive microembolism and normal after massive embolism or CS. Pulmonary embolectomy may prevent disturbances of DLCO or PAP even after CS. Damage of vascular integrity (VC) was found after microembolism. Pulmonary embolectomy seems to remove total embolic material and therefore seems to be optimal.


Assuntos
Complicações Pós-Operatórias/diagnóstico , Capacidade de Difusão Pulmonar/fisiologia , Embolia Pulmonar/cirurgia , Pressão Propulsora Pulmonar/fisiologia , Choque Cardiogênico/cirurgia , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Embolia Pulmonar/diagnóstico , Recidiva , Choque Cardiogênico/diagnóstico
10.
Z Kardiol ; 78(11): 707-13, 1989 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-2609715

RESUMO

Abundant collaterals may prevent infarction in a region of myocardium supplied by an acutely occluded coronary artery. However, these patients often present with severe angina on exertion which cannot be sufficiently treated with antianginal drugs but require revascularization. Beginning in 1984, recanalization of chronic coronary artery occlusion using balloon catheters was attempted in 48 patients at Medizinische Klinik III, University of Cologne. Interventional therapy was successful in 29/48 patients (60%). The mean diameter narrowing of residual stenoses was 35%. Invasive follow-up at 3 months was possible in 17 of these 29 patients. Restenosis was noted in 41% and reocclusion was found in 18%. In contrast to angiographic findings, clinical symptoms were clearly improved in the majority of cases (88%). This correlates with increased regional contractility of the myocardial region supplied by the previously occluded artery. Contractility was also improved in patients with significant restenosis. The clinical benefit and the improvement of regional myocardial function indicate that it is justified to attempt balloon recanalization in highly symptomatic patients with short distance coronary occlusions despite the relatively high incidence of restenosis and reocclusion.


Assuntos
Angioplastia Coronária com Balão , Hemodinâmica , Contração Miocárdica , Infarto do Miocárdio/terapia , Ponte de Artéria Coronária , Circulação Coronária/fisiologia , Eletrocardiografia/instrumentação , Feminino , Seguimentos , Ventrículos do Coração/fisiopatologia , Hemodinâmica/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Contração Miocárdica/fisiologia , Infarto do Miocárdio/fisiopatologia , Recidiva , Processamento de Sinais Assistido por Computador
11.
Z Kardiol ; 77(3): 165-71, 1988 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-2968023

RESUMO

Complications following percutaneous transluminal coronary angioplasty (PTCA), such as coronary artery occlusion, spasm, or dissection, frequently require urgent surgical intervention. Out of 26 patients from our hospital, 12 who underwent emergency coronary bypass grafting because of balloon catheter complications with a total ischemic time of 100-255 min, were restudied in the late postoperative period by clinical examination and by coronary and left ventricular angiography. Left ventricular angiograms were evaluated quantitatively for global and regional function using the AVD system (Siemens Elema, Erlangen). Electronmicroscopic results from myocardial biopsy samples, taken intraoperatively from the presumed center of the ischemic zone, were compared with the clinical results. An improvement of left ventricular function parameters could be seen in patients with reperfusion intervals within 130 min. In the case of intermittent perfusion of the occluded vessel (catheter perfusion with arterial blood, intermittent spasm) operative revascularization proved to salvage jeopardized myocardium. There was a close correlation between the degree of left ventricular dysfunction and histological results, coronary morphology and clinical staging. In conclusion, the efficacy of myocardial protection by emergency bypass surgery depends mainly on coronary morphology and above all on reperfusion intervals.


Assuntos
Ponte de Artéria Coronária , Emergências , Contração Miocárdica , Infarto do Miocárdio/cirurgia , Adulto , Angioplastia com Balão , Biópsia , Débito Cardíaco , Circulação Coronária , Feminino , Humanos , Masculino , Microscopia Eletrônica , Pessoa de Meia-Idade , Infarto do Miocárdio/patologia , Miocárdio/patologia
12.
Langenbecks Arch Chir ; 369: 507-12, 1986.
Artigo em Alemão | MEDLINE | ID: mdl-3807569

RESUMO

Pulmonary angiography is the most reliable diagnostic procedure to establish the diagnosis of pulmonary embolism (high sensitivity and specificity). Therefore it should be performed routinely in the presence of any clinical suspicion of pulmonary embolism (PE) unless PE was excluded by perfusion lung scan or the patient needs urgent operative treatment because of hemodynamical instability. Hemodynamic parameters, blood gas measurements and right ventricular pressures as well are only useful in the therapeutic management and are of limited value in the diagnosis of PE.


Assuntos
Embolia Pulmonar/diagnóstico , Angiografia , Hemodinâmica , Humanos , Prognóstico , Embolia Pulmonar/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...